NRX Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense
NRX Pharmaceuticals, Inc. (NRXP) reported Increase (Decrease) in Prepaid Expense of -$22.50 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2021-03-31 was -$22.50K.
- NRX Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2020-03-31 was $0.00.
| Period end | Increase (Decrease) in Prepaid Expense 3 month |
|---|---|
| 2021-03-31 | -$22.50K 10-Q · filed 2021-05-21 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |